A local biotech company has been awarded $12 million by the National Institutes of Health to develop drugs to fight smallpox and arenaviruses, which can cause hemorrhagic fevers such as ebola. Both are potentially lethal and considered serious threats for use in bioterrorist attacks.The funding will be paid out over the next two years and will allow the company, Siga Technologies, to greatly expand its laboratories and its payroll.
